Bridgebio Pharma, Inc. (BBIO) — SC 13D/A Filings
All SC 13D/A filings from Bridgebio Pharma, Inc.. Browse 3 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (3)
-
Viking Global Investors Amends BridgeBio Pharma Stake
— Nov 6, 2024 Risk: medium
Viking Global Investors LP, through its filing on November 6, 2024, has amended its Schedule 13D for BridgeBio Pharma, Inc. The filing indicates a change in ben -
KKR Entity Amends Stake in BridgeBio Pharma
— Sep 17, 2024 Risk: medium
On September 17, 2024, KKR Genetic Disorder L.P. filed an amendment (Amendment No. 4) to its Schedule 13D regarding BridgeBio Pharma, Inc. The filing indicates -
Viking Global Investors LP Amends BridgeBio Pharma Stake
— Aug 20, 2024 Risk: medium
Viking Global Investors LP, through its affiliates, has amended its Schedule 13D filing regarding BridgeBio Pharma, Inc. The filing, dated August 20, 2024, indi
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX